Chronic hepatitis c Trials in Valencia, Spain
Conditions / Chronic hepatitis c / Valencia, Spain
Chronic hepatitis c has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00402428 | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients | COMPLETED | PHASE3 |
| NCT01513941 | An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) | COMPLETED | PHASE3 |
| NCT01464827 | ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients | COMPLETED | PHASE2 |
| NCT00526448 | Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients | UNKNOWN | PHASE4 |
| NCT00528528 | An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants | COMPLETED | PHASE2 |
| NCT00411385 | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 | COMPLETED | PHASE3 |
| NCT02785835 | Hepatocellular Carcinoma in HIV-infected Patients | COMPLETED | — |
| NCT01625338 | Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies | COMPLETED | PHASE3 |
| NCT00759200 | Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients | COMPLETED | PHASE2 |
| NCT00093093 | Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive | COMPLETED | PHASE3 |